Warning: The NCBI web site requires JavaScript to function. more...
Analysis of N-terminal pro-B-type natriuretic peptide and cardiac index in multiple injured patients: a prospective cohort study.
Kirchhoff C, Leidel BA, Kirchhoff S, Braunstein V, Bogner V, Kreimeier U, Mutschler W, Biberthaler P.
Crit Care. 2008;12(5):R118. Epub 2008 Sep 12.
Related citations
Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
Rev Port Cardiol. 2004 Dec;23(12):1557-82. English, Portuguese.
Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
J Am Coll Cardiol. 2008 May 13;51(19):1874-82.
Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
Bargnoux AS, Klouche K, Fareh J, Barazer I, Villard-Saussine S, Dupuy AM, Leray-Moragues H, Giuliani I, Canaud B, Cristol JP.
Clin Chem Lab Med. 2008;46(7):1019-24.
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M.
Chest. 2006 May;129(5):1313-21.
[N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN, Wierzbowski R, Piechota WT, Bejm J, Gielerak G.
Pol Arch Med Wewn. 2006 Jul;116(1):640-7. Polish.
Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiss C, Kaden JJ, Putensen C, Borggrefe M, Hoffmann U.
Circulation. 2005 Jul 26;112(4):527-34. Epub 2005 Jul 18.
Performance of N-terminal-pro-B-type natriuretic peptide in critically ill patients: a prospective observational cohort study.
Coquet I, Darmon M, Doise JM, Degrès M, Blettery B, Schlemmer B, Gambert P, Quenot JP.
Crit Care. 2008;12(6):R137. Epub 2008 Nov 6.
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. Epub 2007 Dec 18.
Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
Weber M, Hausen M, Arnold R, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C.
Int J Cardiol. 2008 Jul 21;127(3):321-7. Epub 2007 Dec 11.
N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G, Runkel S, Zdunek D, Hitzler WE.
Clin Lab. 2005;51(3-4):167-72.
N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances.
Andreassen M, Faber J, Vestergaard H, Kistorp C, Kristensen LØ.
Clin Endocrinol (Oxf). 2007 May;66(5):619-25.
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Bonaca MP, Wiviott SD, Sabatine MS, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DA.
Am J Cardiol. 2007 Feb 1;99(3):344-8. Epub 2006 Nov 30.
B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
Bal L, Thierry S, Brocas E, Van de Louw A, Pottecher J, Hours S, Moreau MH, Perrin Gachadoat D, Tenaillon A.
Acta Anaesthesiol Scand. 2006 Mar;50(3):340-7.
Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
Clin Biochem. 2006 Jun;39(6):640-5. Epub 2006 Mar 3.
Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism.
Ozmen B, Ozmen D, Parildar Z, Mutaf I, Bayindir O.
Endocr Res. 2007;32(1-2):1-8.
Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.
J Am Coll Cardiol. 2005 May 17;45(10):1667-71.
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C, Emdin M, Zucchelli GC, Ripoli A, Passino C, Clerico A.
Clin Chem Lab Med. 2004 Jan;42(1):37-44.
Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E, Araujo AQ, Buck P, Ianni BM, Rabello R, Mady C.
Am Heart J. 2005 Dec;150(6):1228-32.
Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA.
Clin Endocrinol (Oxf). 1997 Sep;47(3):287-96.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on